- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 15:58 | UK spurs prescribing of obesity jab Mounjaro with GP bonus | ||
| 14:59 | After CagriSema blow, Novo reveals data for obesity 'triple' | ||
| 13:58 | Joy as NICE changes tack on first NHS vitiligo treatment | ||
| 12:58 | MSD splits pharma business, hiving off oncology | ||
| 11:59 | FDA maps new regulatory route for ultra-rare diseases | ||
| Mo | FDA clears first all-oral combo for first-line CLL treatment | ||
| Mo | Gilead buys cell therapy partner Arcellx for up to $7.8bn | ||
| Mo | Head-to-head trial dents Novo Nordisk's obesity hopes | ||
| Mo | Patients struggling with NHS complexity, says report | ||
| Mo | What next for pharma as SCOTUS strikes down Trump tariffs? | ||
| Fr | FDA starts review of Regeneron's drug for rare disease FOP | ||
| Fr | Grail's multi-cancer test fluffs its lines in UK trial | ||
| Fr | UK firm steps in to ease medicine supply crisis in NHS | ||
| Fr | Texas sues Sanofi, claiming kickbacks to doctors | ||
| Fr | Ex-Novartis CMO John Tsai joins Daiichi Sankyo | ||
| Do | Hims & Hers buys Australian digital health firm for $1.15bn | ||
| Do | Makary says FDA will "end two-trial dogma" for approvals | ||
| Do | NICE backs changes to NHS' diabetes care pathway | ||
| Do | NIH Director Bhattacharya will temporarily run CDC | ||
| Do | MSD and Mayo Clinic team up on AI drug discovery | ||
| Mi | FDA relents and will review Moderna's flu shot | ||
| Mi | FDA changes course and agrees to review Moderna's flu shot | ||
| Mi | FDA starts review of BMS's 'celmod' for multiple myeloma | ||
| Mi | Number of UK biotech companies rising, says report | ||
| Mi | Novartis' oral BTK drug moves the needle in CINDU |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.